Brigitte Rigat

7.8k total citations · 3 hit papers
32 papers, 6.5k citations indexed

About

Brigitte Rigat is a scholar working on Physiology, Molecular Biology and Cell Biology. According to data from OpenAlex, Brigitte Rigat has authored 32 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Physiology, 17 papers in Molecular Biology and 11 papers in Cell Biology. Recurrent topics in Brigitte Rigat's work include Lysosomal Storage Disorders Research (18 papers), Glycosylation and Glycoproteins Research (12 papers) and Carbohydrate Chemistry and Synthesis (9 papers). Brigitte Rigat is often cited by papers focused on Lysosomal Storage Disorders Research (18 papers), Glycosylation and Glycoproteins Research (12 papers) and Carbohydrate Chemistry and Synthesis (9 papers). Brigitte Rigat collaborates with scholars based in Canada, United States and France. Brigitte Rigat's co-authors include Florent Soubrier, Pierre Corvol, François Cambien, C. Hübert, F Alhenc‐Gelas, Pierre Corvol, Christine Hübert, Sophie Visvikis‐Siest, Laurence Tiret and Don J. Mahuran and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Brigitte Rigat

32 papers receiving 6.3k citations

Hit Papers

An insertion/deletion pol... 1990 2026 2002 2014 1990 1992 1992 1000 2.0k 3.0k

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Brigitte Rigat 3.9k 2.6k 1.4k 1.2k 1.1k 32 6.5k
Klaus Lindpaintner 4.1k 1.0× 2.3k 0.9× 1.2k 0.9× 2.0k 1.7× 617 0.6× 138 8.2k
F Alhenc‐Gelas 3.1k 0.8× 1.9k 0.7× 924 0.7× 1.2k 1.0× 336 0.3× 25 4.9k
François Alhenc‐Gelas 3.9k 1.0× 2.4k 0.9× 730 0.5× 2.0k 1.7× 550 0.5× 122 6.9k
C. Hübert 2.8k 0.7× 1.7k 0.7× 937 0.7× 1.0k 0.9× 295 0.3× 24 4.4k
V J Dzau 3.8k 1.0× 1.8k 0.7× 400 0.3× 2.2k 1.8× 974 0.9× 76 5.9k
Toshihiro Ichiki 3.5k 0.9× 2.1k 0.8× 305 0.2× 3.4k 2.9× 1.1k 1.0× 111 7.4k
Matsuhiko Hayashi 1.8k 0.5× 1.7k 0.6× 482 0.4× 2.5k 2.1× 582 0.5× 203 6.1k
Hiroyuki Kobori 6.2k 1.6× 5.1k 2.0× 372 0.3× 2.3k 1.9× 864 0.8× 178 10.0k
Sven Waßmann 2.5k 0.6× 1.3k 0.5× 503 0.4× 2.0k 1.7× 1.1k 1.0× 101 7.0k
Óscar Lorenzo 2.3k 0.6× 1.2k 0.4× 264 0.2× 2.4k 2.0× 602 0.6× 110 6.3k

Countries citing papers authored by Brigitte Rigat

Since Specialization
Citations

This map shows the geographic impact of Brigitte Rigat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brigitte Rigat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brigitte Rigat more than expected).

Fields of papers citing papers by Brigitte Rigat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brigitte Rigat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brigitte Rigat. The network helps show where Brigitte Rigat may publish in the future.

Co-authorship network of co-authors of Brigitte Rigat

This figure shows the co-authorship network connecting the top 25 collaborators of Brigitte Rigat. A scholar is included among the top collaborators of Brigitte Rigat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brigitte Rigat. Brigitte Rigat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Caridi, Gianluca, Francesca Lugani, Brigitte Rigat, et al.. (2018). A novel insertion (c.1098dupT) in the albumin gene causes analbuminemia in a consanguineous family. European Journal of Medical Genetics. 62(2). 144–148. 4 indexed citations
2.
4.
Schitter, Georg, Andreas Steiner, Arnold Stütz, et al.. (2010). Synthesis of lipophilic 1-deoxygalactonojirimycin derivatives as D-galactosidase inhibitors. Beilstein Journal of Organic Chemistry. 6. 21–21. 17 indexed citations
5.
Clarke, Joe T.R., Don J. Mahuran, Swati Sathe, et al.. (2010). An open-label Phase I/II clinical trial of pyrimethamine for the treatment of patients affected with chronic GM2 gangliosidosis (Tay–Sachs or Sandhoff variants). Molecular Genetics and Metabolism. 102(1). 6–12. 89 indexed citations
6.
Schitter, Georg, Andreas Steiner, Gerit Pototschnig, et al.. (2010). Fluorous Iminoalditols: A New Family of Glycosidase Inhibitors and Pharmacological Chaperones. ChemBioChem. 11(14). 2026–2033. 41 indexed citations
7.
Khanna, Richie, Elfrida R. Benjamin, Lee Pellegrino, et al.. (2010). The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of β‐glucosidase. FEBS Journal. 277(7). 1618–1638. 127 indexed citations
8.
Furneaux, Richard H., Don J. Mahuran, Brigitte Rigat, et al.. (2010). 1-Deoxynojirimycins with dansyl capped N-substituents as probes for Morbus Gaucher affected cell lines. Carbohydrate Research. 345(10). 1371–1376. 11 indexed citations
9.
Tropak, Michael B., et al.. (2009). A sensitive fluorescence-based assay for monitoring GM2 ganglioside hydrolysis in live patient cells and their lysates. Glycobiology. 20(3). 356–365. 22 indexed citations
10.
Rigat, Brigitte, Herman Yeger, Darakhshanda Shehnaz, & Don J. Mahuran. (2009). GM2 activator protein inhibits platelet activating factor signaling in rats. Biochemical and Biophysical Research Communications. 385(4). 576–580. 8 indexed citations
11.
Maegawa, Gustavo, Michael B. Tropak, Brigitte Rigat, et al.. (2009). Identification and Characterization of Ambroxol as an Enzyme Enhancement Agent for Gaucher Disease. Journal of Biological Chemistry. 284(35). 23502–23516. 260 indexed citations
12.
Rigat, Brigitte & Don J. Mahuran. (2009). Diltiazem, a L-type Ca2+ channel blocker, also acts as a pharmacological chaperone in Gaucher patient cells. Molecular Genetics and Metabolism. 96(4). 225–232. 39 indexed citations
13.
Bagshaw, Richard D., et al.. (2008). Cryptic splice site in the complementary DNA of glucocerebrosidase causes inefficient expression. Analytical Biochemistry. 381(2). 276–278. 3 indexed citations
14.
Martin, Douglas R., Brigitte Rigat, Polly Foureman, et al.. (2008). Molecular consequences of the pathogenic mutation in feline GM1 gangliosidosis. Molecular Genetics and Metabolism. 94(2). 212–221. 33 indexed citations
15.
Chen, Biao, Brigitte Rigat, Cynthia J. Curry, & Don J. Mahuran. (1999). Structure of the GM2A Gene: Identification of an Exon 2 Nonsense Mutation and a Naturally Occurring Transcript with an In-Frame Deletion of Exon 2. The American Journal of Human Genetics. 65(1). 77–87. 25 indexed citations
16.
Carbone, Mary Anna, N. MacKay, Mingfu Ling, et al.. (1998). Amerindian Pyruvate Carboxylase Deficiency Is Associated with Two Distinct Missense Mutations. The American Journal of Human Genetics. 62(6). 1312–1319. 38 indexed citations
17.
MacKay, N., et al.. (1994). cDNA Cloning of Human Kidney Pyruvate Carboxylase. Biochemical and Biophysical Research Communications. 202(2). 1009–1014. 19 indexed citations
18.
Rigat, Brigitte, et al.. (1992). PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Research. 20(6). 1433–1433. 1109 indexed citations breakdown →
19.
Rigat, Brigitte, et al.. (1992). Sib pair linkage analysis of renin gene haplotypes in human essential hypertension. Human Genetics. 88(3). 301–6. 81 indexed citations
20.
Rigat, Brigitte, C. Hübert, F Alhenc‐Gelas, et al.. (1990). An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.. Journal of Clinical Investigation. 86(4). 1343–1346. 3121 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026